William Breslin,
PhD

Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring

Dr. Breslin is an internationally recognized expert in reproductive and developmental toxicology, with extensive experience in general toxicology. He has held leadership positions, directing regulatory, scientifi c, and laboratory operations for nonclinical safety assessment in the pharmaceutical (18 years at Eli Lilly and Co.), chemical (12 years at Dow Chemical Co.) and contract research (2 years at MPI Research) industries. Dr. Breslin is currently President/Owner of Breslin Toxicology Consulting, LLC.